Akshay Vaishnaw M.D., Ph.D.
President, R&D
Dr. Akshay Vaishnaw has served as President of R&D of Scholar Rock since April 2025. Prior, he served as a member of Scholar Rock’s board of directors from May 2019 until April 2025. He is a venture partner with over 25 years of experience in the biotechnology industry. Since 2006, he served in positions of increasing responsibility across Research and Development (R&D) at Alnylam Pharmaceuticals, and most recently served as President of Alnylam Pharmaceuticals. Previously, Akshay held various positions in clinical research and business development at Biogen.
He is a board member Hemab and the non-profit, TB Alliance. Previously, he served on the Boards of Visterra, Inc, and Editas Medicine Inc.
Akshay received a bachelor’s degree from University College Cardiff, UK, an MD from the University of Wales College of Medicine, UK, and a PhD from the University of London, UK, in Molecular Immunology. He is a Fellow of the Royal College of Physicians, UK.
